Bupropion Hydrochloride Extended-release

DRUG2 trials

Sponsors

GlaxoSmithKline, Yale University

Conditions

Bariatric Surgery PatientsDepressive Disorder, MajorMajor Depressive Disorder (MDD)ObesitySmoking Cessation

Phase 1

A Multiple Health Behavior Change (MHBC) Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients

Not yet recruitingNCT07398404

Yale UniversityBariatric Surgery Patients, Obesity, Smoking Cessation

Start: 2026-07-01End: 2031-06-30Target: 64Updated: 2026-03-20

Phase 4

Sexual Functioning Study With Antidepressants

CompletedNCT00316160

GlaxoSmithKlineDepressive Disorder, Major, Major Depressive Disorder (MDD)

Start: 2004-09-30End: 2005-05-31Target: 347Updated: 2017-05-30